Last updated: March 22, 2024
Sponsor: Cardiff and Vale University Health Board
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pneumonia
Treatment
PneuX Endotracheal Tube
Standard care (Taperguard, Covidien)
Clinical Study ID
NCT05410106
21/NOV/8290
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 years old (no upper age)
- Patient required endotracheal intubation
- Expect to remain intubated for 24 hours post randomisation
Exclusion
Exclusion Criteria:
- The person intubating the patient assesses that the patient has already aspirated.
- GCS 7 or less on presentation to hospital
- Patient is pregnant
- Patient has tracheostomy
- Patient has gastrectomy
- Patients who have been intubated prior to arrival at hospital
- Patients who are already endotracheally intubated and require a tube change.
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: PneuX Endotracheal Tube
Phase:
Study Start date:
December 05, 2022
Estimated Completion Date:
December 31, 2024
Connect with a study center
University Hospital of Wales
Cardiff, CF14 4XW
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.